ascopubs.org4d
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update
Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the EMERALD Study ASCO Guidelines provide recommendations with ...
Oncology Nurse Advisor2d
ASCO Updates Guidelines for Ovarian Cancer
The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...
BMJ4d
A review of salivary gland histopathology in primary Sjögren's syndrome with a focus on its potential as a clinical trials biomarker
Salivary gland changes, characterised by a focal lymphocytic sialadenitits, play an important role in the diagnosis of primary Sjögren's syndrome (PSS) and were first described over 40 years ago.
gut.bmj2d
The pathogenesis of duodenal gastric metaplasia: the role of local goblet cell transformation
30 Transitional forms between serous and mucous cells, and clara and mucous cells also appear in respiratory epithelium when exposed to irritants31 and are followed by mucous cell hyperplasia. It is ...
gut.bmj6d
Loss of interstitial cells and a fibromuscular layer on the luminal side of the colonic circular muscle presenting as megacolon in an adult patient
He had a high titre of circulating serum anti-neuronal nuclear antibodies. METHODS Histology, immunocytochemistry (for neurofilaments, neurone specific enolase, synaptophysin, glial fibrillar acidic ...
asco.org4d
PTEN loss as a context-dependent determinant of patient outcomes in obese and non-obese endometrioid endometrial cancer patients.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org4d
Assessment of a custom designed next generation DNA sequencing gene panel to profile endometrial cancers.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...